NCT02643628.

Trial name or title	A pilot study to evaluate the safety and effectiveness of microneedling and bellafill to treat facial acne scars
Methods	Open‐label, parallel, randomised, multicentre, prospective trial Primary purpose: treatment
Participants	45 individuals with distensible atrophic acne scars Ages eligible for study: 21+ Genders eligible for study: both
Interventions	Arm 1: microneedling Arm 2: microneedling followed by injectable filler
Outcomes	Acne scar assessment scale: time frame 6 months
Starting date	November 2015
Contact information	Nancy Seretta (nserreta@sunevamedical.com)
Notes	NCT02643628 Sponsor: Suneva Medical, Inc Country: USA